Dados B3 › CEGR3 × EGIE3
CEGR3 × EGIE3
Indicators
Each row uses the most recent year in which BOTH companies have the figure, and says which year that is. A cell with ! carries a caveat — hover to read it. We do not name a winner: that would be a recommendation, and this site does not give any.
| indicator | CEGR3 | EGIE3 | year |
|---|---|---|---|
| ROE | 33.8%! | 21.5% | 2025 |
| ROIC | 29.0% | 13.9% | 2025 |
| ROA | 13.2% | 5.4% | 2025 |
| Gross margin | 33.2% | 46.7% | 2025 |
| EBIT margin | 21.7% | 48.7% | 2025 |
| Net margin | 12.8% | 22.2% | 2025 |
| Net debt/EBITDA | 0.43x | 3.30x | 2025 |
| Current ratio | 0.70x | 1.12x | 2025 |
| Revenue growth (1y) | -6.9% | 14.6% | 2025 |
| Revenue growth (5y CAGR) | 8.6% | 1.0% | 2025 |
| Piotroski F-Score | 7/9 | 5/9 | 2025 |
Point-in-time multiples
Priced at the first session on or after the day each filing became public — never the period close.
| indicator | CEGR3 | EGIE3 | year |
|---|---|---|---|
| P/E | 14.91x | 14.21x | 2025 |
| P/B | 4.49x | 2.88x | 2025 |
| EV/EBITDA | 7.97x | 8.09x | 2025 |
| FCF yield | 4.2% | 4.3% | 2025 |
Numbers on this page are live. Data version 2026-09-27-reapresentacao-agreg · page generated 2026-09-27 07:30 UTC. If this does not match /saude, you are reading a cached copy.
Sources: CVM (open data, ODbL) and B3 (COTAHIST). Not affiliated with B3 or the CVM. Not investment advice.
Numbers on this page are live. Data version 2026-09-27-reapresentacao-agreg · page generated 2026-09-27 07:30 UTC. If this does not match /saude, you are reading a cached copy.